Filter
1250
Text search:
drug
regulation
Featured
88
353
Language
Document type
668
246
163
68
66
14
12
8
3
1
1
Countries
65
52
50
44
36
36
31
30
28
23
22
21
20
20
19
18
18
17
15
15
15
15
14
14
12
12
11
11
11
11
8
8
7
6
5
5
5
4
4
4
4
4
4
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
555
84
74
36
32
20
10
Toolboxes
153
124
80
71
44
34
33
28
22
19
19
18
14
13
12
12
11
11
7
6
5
3
3
1
This document builds on the Background document prepared for the September 4-5, 2014 Consultation. It includes proposed elements to consider during the development of a framework to assist decision-making at global and national level.
The aim of the document is to assist Member States and releva
...
Promoting People's Health to Enhance Social-economic Development
Global UNIDO Project: Strengthening the local production of essential generic drugs in the least developed and developing countries
The Primary Care Innovator’s Handbook
recommended
Voices from Leaders in the Field
A survey was conducted in countries in all six WHO regions and focused on the building blocks that are considered prerequisites to combat antimicrobial resistance: a comprehensive national plan, laboratory capacity to undertake surveillance for resistant microorganisms, access to safe, effective ant
...
Clinical Infectious Diseases 2010; 50:291–322
Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, WHO has developed a system of indicators that measure important aspects of a country’s pharmaceutical situation. Level 1 indicators measure the existence and
...
Reach the Unreached - FIND, TREAT, CURE TB, SAVE LIVES
Supplement to the Healthcare Waste Management Toolkit for Global Fund
Practitioners and Policy Makers
